Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: A case series

Depression and Anxiety

Volumn 12, Issue 1, 2000, Pages 44-50

  Bouwer, Colin ^a   Claassen, Johann ^a   Dinan, Timothy G ^b   Nemeroff, Charles B ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Ftigue; Hypocortisolaemia; Hypothalamic; Pitpituiry adrena l axis; Prednisone

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; HYDROCORTISONE; IMIPRAMINE; LOFEPRAMINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PREDNISONE; SERTRALINE; TRANYLCYPROMINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; DRUG POTENTIATION; ELECTROCONVULSIVE THERAPY; FATIGUE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADRENAL INSUFFICIENCY; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PREDNISONE; SYNDROME; TREATMENT OUTCOME;

EID: 0033846915     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6394(2000)12:1<44::AID-DA6>3.0.CO;2-C     Document Type: Article

References (50)

1. Pituitary and adrenocortical responses the ovine corticotropin releasing hormone in depressed patients and healthy volunteers
2. Psychiatric manifestations of endocrine disorder
3. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
4. Developmental and personality correlates of adrenocortical activity as indexed by salivary cortisol: Observations in the age range of 35 to 65 years
5. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
6. A specific laboratory test for the diagnosis of melancholia
7. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
8. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial
9. A specific non-chromatograph radioimmunoassay for human cortisol
10. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls
11. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
12. Glucocorticoids and the genesis of depressive illness
13. Dexamethasone augmentation in treatment-resistant depression
14. Brain disorders associated with endocrine dysfunction
15. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis
16. The chronic fatigue syndrome: A comprehensive approach to its treatment and study
17. An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome
18. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
19. Clinical and biochemical manifestations of depression: II. Relation to the neurobiology of stress
20. The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolism
21. A rating scale for depression
22. Chronic fatigue syndrome: A working case definition
23. Corticotropin-releasing hormone a new tool to investigate hypothalamic-pituitary-adrenocortical physiology in psychiatric patients
24. ACTH, cortisol and corticosterone output after ovine corticoptrin-releasing factor challenge during depression and after recovery
25. Psychiatric manifestations of Cushing's syndrome: Response to lowering of plasma cortisol
26. Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: Clinical and pathophysiological implications
27. Hooked on hormones? An anabolic steroid addiction hypothesis
28. Cushing's syndrome, tryptophan and depression
29. Cybernetics, activation, and drug effects
30. Stress-response neurohormonal systems and the symptom complex of affective illness
31. The corticotropin releasing factor stimulation test in patients with major depression: Relationship to dexamethasone suppression test results
32. An enzyme linked immunosorbent (ELISA) assay for urinary free cortisol
33. Side effects of corticosteroid therapy: Psychiatric aspects
34. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial
35. Treatment of major depression with steroid suppressive drugs
36. Response to steroid suppression in major depression resistant to antidepressant therapy
37. Adrenal gland enlargement in major depression: A computed tomographic study
38. Treatment of major depression with metyrapone and hydrocortisone
39. Adrenal insufficiency
40. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome
41. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretary dynamics in patients and matched controls
42. The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis
43. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder
44. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
45. Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression
46. Ketaconazole administration in hypercortisolaemic depression
47. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
48. High self-esteem, hardiness and affective stability are associated with higher basal pituitary-adrenal hormone levels